4-Cyclohexylbutanoic acid (EBC-12682)
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1716-12-7
Purity
95%
Phenylbutyric acid is an agent indicated for the adjunctive therapy for the management of chronic urea cycle disorders due to deficiencies in specific enzymes, including the neonatal-onset deficiency and late-onset disease with a history of hyperammonemic encephalopathy. Sodium phenylbutyrate is a pro-drug that is metabolized to the active compound phenylacetate.
Properties
Name
Sodium Phenylbutyrate
Smiles
[Na+].[O-]C(=O)CCCC=1C=CC=CC1
Targets
Please log in to see this information
SDS
4-phenylbutyric acid sodium salt | 4PBA | Ammonaps | PBA | SPB | sodium 4-phenylbutanoate | sodium 4-phenylbutyrate | sodium phenylbutyrate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
4-phenylbutyric acid sodium salt | 4PBA | Ammonaps | PBA | SPB | sodium 4-phenylbutanoate | sodium 4-phenylbutyrate | sodium phenylbutyrate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.